What is the treatment for pompholyx?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pompholyx (Dyshidrotic Eczema)

Topical corticosteroids are the first-line treatment for pompholyx, with calcineurin inhibitors serving as effective alternatives, particularly for maintenance therapy. 1

First-Line Treatments

Topical Therapies

  • Topical corticosteroids: Cornerstone of initial treatment

    • Use potent formulations for acute flares
    • Apply to affected areas on palms and soles
    • Taper to lower potency formulations as condition improves
    • Occlusive dressings may enhance penetration through thick palmoplantar skin
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus)

    • Effective alternative to corticosteroids
    • Particularly useful for maintenance therapy
    • Avoids steroid-related side effects with prolonged use
    • Apply twice daily to affected areas

Second-Line Treatments

Phototherapy Options

  • Topical PUVA (psoralen plus UVA)

    • As effective as systemic photochemotherapy 1
    • Apply methoxsalen (8-methoxypsoralen) followed by UVA exposure
    • Typically 2-3 sessions per week
  • High-dose UVA-1 irradiation

    • Effective alternative phototherapy option
    • Requires specialized equipment 2

Systemic Treatments for Severe Cases

  • Systemic corticosteroids

    • For severe bullous pompholyx
    • Short courses to control acute flares
    • Taper to avoid rebound flares
  • Alitretinoin

    • Effective for chronic hand dermatitis including pompholyx
    • Particularly useful for resistant cases 2, 3
    • May work by regulating aquaporin expression in the skin 3

Treatment for Recalcitrant Cases

  • Botulinum toxin A injections

    • Intradermal injection for treatment-resistant cases
    • Reduces hyperhidrosis which may trigger flares 1, 2, 4
    • Effect typically lasts 3-6 months
  • Methotrexate

    • Low-dose oral methotrexate for severe recalcitrant cases
    • Acts as a steroid-sparing agent
    • Can lead to significant improvement or clearing 5
    • Requires monitoring for potential side effects
  • Combination immunosuppressive therapy

    • For highly resistant cases
    • Corticosteroids combined with other immunosuppressants 1

Management Approach

  1. Initial Assessment:

    • Identify and eliminate potential triggers (irritants, allergens)
    • Assess severity and extent of vesicles/bullae
  2. Mild to Moderate Disease:

    • Start with potent topical corticosteroids
    • Consider topical calcineurin inhibitors for maintenance
  3. Severe or Widespread Disease:

    • Short course of systemic corticosteroids
    • Consider phototherapy (PUVA or high-dose UVA-1)
  4. Recalcitrant Disease:

    • Alitretinoin
    • Botulinum toxin injections
    • Low-dose methotrexate

Important Considerations

  • The thick horny layer of palms and soles makes treatment challenging 1
  • Patients often benefit most from combination therapies 1
  • Maintenance therapy is important to prevent relapses
  • Addressing hyperhidrosis may help prevent recurrences

Pitfalls to Avoid

  • Prolonged use of high-potency topical steroids without breaks (risk of skin atrophy)
  • Failure to identify and address triggers
  • Inadequate patient education about chronic nature of condition
  • Discontinuing treatments too quickly after improvement (leads to relapses)

References

Research

Pompholyx: what's new?

Expert opinion on investigational drugs, 2008

Research

Pharmacotherapy of pompholyx.

Expert opinion on pharmacotherapy, 2004

Research

Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.